Join our journey
A Norwegian life-science company solving one of the largest medical challenges we are facing.
20 minutes delay

Lifecare as an investment

Lifecare’s purpose is to develop and license technology for medical use, including facilitating the production and sale of medical devices. Today people with diabetes are dependent on a painful and more than 40-year-old technology. Lifecare’s solutions have the potential to revolutionise the field of continuous glucose measurement for more the more than 530 million people living with diabetes.

 

Top 10 shareholders

Updated July 25, 2024
Name
Holdings
Share
Citizen
Lacal AS
28 643 699
14.77 %
NOR
Teigland Eiendom AS
27 315 777
14.09 %
NOR
Tjelta AS
11 683 587
6.03 %
NOR
VPF Nordea Avkastning
9 165 713
4.73 %
NOR
Nordnet Livsforsikring AS
5 211 402
2.69 %
NOR
F2 Funds As
4 631 136
2.39 %
NOR
Spit Air AS
4 587 735
2.37 %
NOR
Even Harald Einarsen
3 400 000
1.75 %
NOR
Lt Finans As
2 893 592
1.49 %
NOR
Nordnet Bank Ab
2 801 772
1.44 %
NOR
Swipe for more data

Contact

Investor relations